Flindt-Hansen H, Tikjøb G, Brandrup F
Acta Derm Venereol. 1984;64(2):177-9.
In order to investigate the efficacy of anthralin ( Anthraderm ) in the treatment of warts a randomized controlled trial was carried out in 72 patients. During a two-month period of treatment 56% were cured in the group treated with anthralin 2% ( Anthraderm ), evaluated at follow-up 2-9 months after finishing treatment, compared with 26% in the group treated with the comparative drug ( Verucid ). Anthralin 2% ( Anthraderm ) was found to have a significantly better effect, especially in the group of patients with warts solely on the hands.
为了研究蒽林（Anthraderm）治疗疣的疗效，对72例患者进行了一项随机对照试验。在为期两个月的治疗期间，使用2%蒽林（Anthraderm）治疗的组中，56%的患者在治疗结束后2至9个月的随访中被治愈，而使用对照药物（Verucid）治疗的组中这一比例为26%。结果发现，2%蒽林（Anthraderm）的疗效明显更好，尤其是对于仅手部患有疣的患者组。
